These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20532049)

  • 1. Drug interaction: focusing on response surface models.
    Lee SI
    Korean J Anesthesiol; 2010 May; 58(5):421-34. PubMed ID: 20532049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive Dose Response Models: Defining Synergy.
    Lederer S; Dijkstra TMH; Heskes T
    Front Pharmacol; 2019; 10():1384. PubMed ID: 31849651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.
    Meletiadis J; Verweij PE; TeDorsthorst DT; Meis JF; Mouton JW
    Med Mycol; 2005 Mar; 43(2):133-52. PubMed ID: 15832557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory of synergistic effects: Hill-type response surfaces as 'null-interaction' models for mixtures.
    Schindler M
    Theor Biol Med Model; 2017 Aug; 14(1):15. PubMed ID: 28768512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism.
    Kashif M; Andersson C; Mansoori S; Larsson R; Nygren P; Gustafsson MG
    Oncotarget; 2017 Nov; 8(61):103952-103967. PubMed ID: 29262612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition.
    Lederer S; Dijkstra TMH; Heskes T
    Front Pharmacol; 2018; 9():31. PubMed ID: 29467650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A generalized response surface model with varying relative potency for assessing drug interaction.
    Kong M; Lee JJ
    Biometrics; 2006 Dec; 62(4):986-95. PubMed ID: 17156272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is synergy? The Saariselkä agreement revisited.
    Tang J; Wennerberg K; Aittokallio T
    Front Pharmacol; 2015; 6():181. PubMed ID: 26388771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel dose-response curves in combination experiments.
    Sühnel J
    Bull Math Biol; 1998 Mar; 60(2):197-213. PubMed ID: 9559575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible interaction model for complex interactions of multiple anesthetics.
    Fidler M; Kern SE
    Anesthesiology; 2006 Aug; 105(2):286-96. PubMed ID: 16871062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial combinations: Bliss independence and Loewe additivity derived from mechanistic multi-hit models.
    Baeder DY; Yu G; Hozé N; Rolff J; Regoes RR
    Philos Trans R Soc Lond B Biol Sci; 2016 May; 371(1695):. PubMed ID: 27160596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.
    Goldoni M; Johansson C
    Toxicol In Vitro; 2007 Aug; 21(5):759-69. PubMed ID: 17420112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-parametric synergy modeling of chemical compounds with Gaussian processes.
    Shapovalova Y; Heskes T; Dijkstra T
    BMC Bioinformatics; 2022 Jan; 23(1):14. PubMed ID: 34991440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Methods for Quantifying Drug Synergism.
    Ma J; Motsinger-Reif A
    Proteom Bioinform; 2019 Jul; 1(2):43-48. PubMed ID: 32043089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction index and different methods for determining drug interaction in combination therapy.
    Lee JJ; Kong M; Ayers GD; Lotan R
    J Biopharm Stat; 2007; 17(3):461-80. PubMed ID: 17479394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response surface models in the field of anesthesia: A crash course.
    Liou JY; Tsou MY; Ting CK
    Acta Anaesthesiol Taiwan; 2015 Dec; 53(4):139-45. PubMed ID: 26321504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling synergistic effects by using general Hill-type response surfaces describing drug interactions.
    Schindler M
    Sci Rep; 2022 Jun; 12(1):10524. PubMed ID: 35732854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.
    Meletiadis J; Mouton JW; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2003 Jan; 47(1):106-17. PubMed ID: 12499177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple test for synergy for a small number of combinations.
    Novick SJ
    Stat Med; 2013 Dec; 32(29):5145-55. PubMed ID: 23904140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations.
    Chen C; Wicha SG; Nordgren R; Simonsson USH
    AAPS J; 2018 Jun; 20(4):77. PubMed ID: 29931471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.